Post-streptococcal glomerulonephritis historical perspective

Jump to navigation Jump to search

Post-streptococcal glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Post-streptococcal glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Post-streptococcal glomerulonephritis historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Post-streptococcal glomerulonephritis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Post-streptococcal glomerulonephritis historical perspective

CDC on Post-streptococcal glomerulonephritis historical perspective

Post-streptococcal glomerulonephritis historical perspective in the news

Blogs on Post-streptococcal glomerulonephritis historical perspective

Directions to Hospitals Treating Post-streptococcal glomerulonephritis

Risk calculators and risk factors for Post-streptococcal glomerulonephritis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

Klebs and colleagues showed that the clinical findings were consistent with a form of glomerulonephritis that was associated with the period following scarlet fever. In 1812, Wells showed that a latent period was required for edema and red urine seem to be present. In 1905 and 1933, Reichel and Osman further elaborated on PSGN and revealed detailed findings and description of the disease, its prevalence, its clinical findings, and its outcome, respectively. In 1903 when Clemens von Pirquet hypothesized the presence of immune complexes that might be the culprit of PSGN. In 1941, Seegal and Earle determined the nephritogenic properties of streptococcal strains and differentiated streptococcal strains based on their nephritogenic vs. rheumatic complication.

Historical Perspective

  • In 1812, Wells showed that a latent period was required for edema and red urine seem to be present.[1]
  • Klebs and colleagues showed that the clinical findings were consistent with a form of glomerulonephritis that was associated with the period following scarlet fever.
  • In 1905 and 1933, Reichel and Osman further elaborated on PSGN and revealed detailed findings and description of the disease, its prevalence, its clinical findings, and its outcome, respectively.
  • In 1903 when Clemens von Pirquet hypothesized the presence of immune complexes that might be the culprit of PSGN, based on his clinical observations during his pediatric residency training. His theory was outlined and sent to the Academy of Sciences in Vienna and was read in the Academy in 1908.[2]
  • In 1941, Seegal and Earle determined the nephritogenic properties of streptococcal strains and differentiated streptococcal strains based on their nephritogenic vs. rheumatic complication.

References

  1. Becker CG, Murphy GE (1968). "The experimental induction of glomerulonephritis like that in man by infection with group A streptococci". J Exp Med. 127 (1): 1–24. PMC 2138440. PMID 5635039.
  2. Rodríguez-Iturbe B, Batsford S (2007). "Pathogenesis of post-streptococcal glomerulonephritis a century after Clemens von Pirquet". Kidney Int. 71 (11): 1094–104. doi:10.1038/sj.ki.5002169. PMID 17342179.

Template:WH Template:WS